androgen_med anxiety_med
Name
antihistamines_med
Label
Antihistamine: Self-reported use
Description

Self-reported drugs at PSG visit, open text then grouped according to effect

Domain
takingornot
  • 0: Not taking
  • 1: Taking
Type
choices
Antihistamine: Self-reported use vs Study visit number
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Incident Outcomes Tracking
Total 1,123 758 566 121 2 -
Not taking 1,035 670 487 105 1 -
Taking 88 88 79 16 1 -
Antihistamine: Self-reported use vs Sex of the participant
Visit 1
Male Female Total
Total 608 515 1,123
Not taking 569 466 1,035
Taking 39 49 88
Antihistamine: Self-reported use vs Sex of the participant
Visit 2
Male Female Total
Total 406 352 758
Not taking 374 296 670
Taking 32 56 88
Antihistamine: Self-reported use vs Sex of the participant
Visit 3
Male Female Total
Total 304 262 566
Not taking 272 215 487
Taking 32 47 79
Antihistamine: Self-reported use vs Sex of the participant
Visit 4
Male Female Total
Total 67 54 121
Not taking 62 43 105
Taking 5 11 16
Antihistamine: Self-reported use vs Sex of the participant
Visit 5
Male Female Total
Total - 2 2
Not taking - 1 1
Taking - 1 1
Antihistamine: Self-reported use vs Race of the participant
Visit 1
Asian Black Hispanic Native American White Total
Total 12 23 13 10 1,065 1,123
Not taking 12 20 12 8 983 1,035
Taking - 3 1 2 82 88
Antihistamine: Self-reported use vs Race of the participant
Visit 2
Asian Black Hispanic Native American White Total
Total 4 8 6 6 734 758
Not taking 4 8 6 4 648 670
Taking - - - 2 86 88
Antihistamine: Self-reported use vs Race of the participant
Visit 3
Asian Black Hispanic Native American White Total
Total 4 4 5 4 549 566
Not taking 4 4 5 3 471 487
Taking - - - 1 78 79
Antihistamine: Self-reported use vs Race of the participant
Visit 4
Asian Black Hispanic Native American White Total
Total 3 1 2 2 113 121
Not taking 2 1 1 2 99 105
Taking 1 - 1 - 14 16
Antihistamine: Self-reported use vs Race of the participant
Visit 5
Asian Black Hispanic Native American White Total
Total - - - - 2 2
Not taking - - - - 1 1
Taking - - - - 1 1